Literature DB >> 8352456

The hypotriglyceridemic effect of fish oil in adult-onset diabetes without adverse glucose control.

W E Connor1, M J Prince, D Ullmann, M Riddle, L Hatcher, F E Smith, D Wilson.   

Abstract

Diabetic control as judged by five criteria did not deteriorate after 6 months of fish oil compared to 6 months of olive oil supplementation in 16 patients with NIDDM who were eating a low fat, high complex carbohydrate diet. Plasma total and VLDL triglyceride and cholesterol decreased significantly after fish oil supplementation; plasma total and HDL cholesterol concentrations did not change. The LDL cholesterol level was significantly increased with fish oil supplementation, suggesting that patients with NIDDM who are given a fish oil supplement to decrease the plasma total and VLDL triglyceride levels may also need further dietary and/or pharmaceutical therapy to maintain an LDL cholesterol level compatible with a low risk of coronary disease. The study emphasizes the safe use of fish oil over a 6-month period in diabetic patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8352456     DOI: 10.1111/j.1749-6632.1993.tb35725.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  11 in total

1.  Meta-analysis of the effects of n-3 polyunsaturated fatty acids on haematological and thrombogenic factors in type 2 diabetes.

Authors:  J Hartweg; A J Farmer; R R Holman; H A W Neil
Journal:  Diabetologia       Date:  2006-11-21       Impact factor: 10.122

Review 2.  Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy.

Authors:  Richard J Woodman; Gerard T Chew; Gerald F Watts
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Marine lipids normalize cholesteryl ester transfer in IDDM.

Authors:  J D Bagdade; M Ritter; P V Subbaiah
Journal:  Diabetologia       Date:  1996-04       Impact factor: 10.122

Review 4.  n-3 fatty acids and lipoproteins: comparison of results from human and animal studies.

Authors:  W S Harris
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

5.  An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia.

Authors:  P N Durrington; D Bhatnagar; M I Mackness; J Morgan; K Julier; M A Khan; M France
Journal:  Heart       Date:  2001-05       Impact factor: 5.994

Review 6.  Omega 3 fatty acids for prevention and treatment of cardiovascular disease.

Authors:  L Hooper; R L Thompson; R A Harrison; C D Summerbell; H Moore; H V Worthington; P N Durrington; A R Ness; N E Capps; G Davey Smith; R A Riemersma; S B J Ebrahim
Journal:  Cochrane Database Syst Rev       Date:  2004-10-18

Review 7.  Dietary fats and diabetes mellitus: is there a good fat?

Authors:  C J Segal-Isaacson; E Carello; J Wylie-Rosett
Journal:  Curr Diab Rep       Date:  2001-10       Impact factor: 4.810

Review 8.  Meta-analysis of the effects of n-3 polyunsaturated fatty acids on lipoproteins and other emerging lipid cardiovascular risk markers in patients with type 2 diabetes.

Authors:  J Hartweg; A J Farmer; R Perera; R R Holman; H A W Neil
Journal:  Diabetologia       Date:  2007-05-31       Impact factor: 10.122

Review 9.  Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus.

Authors:  J Hartweg; R Perera; V Montori; S Dinneen; H A W Neil; A Farmer
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23

10.  Polymorphisms in Fatty Acid Desaturase (FADS) Gene Cluster: Effects on Glycemic Controls Following an Omega-3 Polyunsaturated Fatty Acids (PUFA) Supplementation.

Authors:  Hubert Cormier; Iwona Rudkowska; Elisabeth Thifault; Simone Lemieux; Patrick Couture; Marie-Claude Vohl
Journal:  Genes (Basel)       Date:  2013-09-10       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.